Darvocet 100mg: Historical Uses, Ingredients, and Safety Information

Darvocet 100mg, commonly known as Darvocet-N 100, was a prescription combination medication historically used for pain relief. Each tablet contained propoxyphene napsylate 100mg and acetaminophen 650mg. Although the medication was previously prescribed for mild to moderate pain, propoxyphene-containing medicines were withdrawn from the United States market in 2010 after safety reviews identified potentially serious or fatal heart-rhythm abnormalities. This page provides historical medication information rather than a recommendation for current use.

What Was Darvocet-N 100?

Darvocet-N 100 combined two active ingredients: propoxyphene napsylate, an opioid pain reliever, and acetaminophen, a non-opioid analgesic. Propoxyphene acted on the central nervous system to change how the body perceived pain, while acetaminophen contributed an additional pain-relieving effect.

The 100mg designation referred to the amount of propoxyphene napsylate in each tablet. The formulation also contained 650mg of acetaminophen. This combination differed from Darvocet-N 50, which contained 50mg of propoxyphene napsylate and 325mg of acetaminophen per tablet. Understanding the complete formulation is important when reviewing historical medication labels or medical records.

Historical Medical Uses

Darvocet-N 100 was historically prescribed for mild to moderate pain. Clinicians considered the nature of the pain, the patient’s medical history, and other medicines before prescribing opioid-containing products.

Its opioid component could produce pain relief but also carried risks associated with opioid medications, including sedation, impaired alertness, physical dependence, and misuse. Acetaminophen also presented a risk of liver injury if excessive amounts were consumed, especially when combined with other medicines containing the same ingredient.

These historical uses should not be interpreted as evidence that Darvocet is appropriate or available for treatment today. People experiencing ongoing pain should consult a healthcare professional about currently available options suited to their symptoms and health circumstances.

Why Was Darvocet Withdrawn?

In November 2010, the U.S. Food and Drug Administration requested the withdrawal of propoxyphene-containing medicines, including Darvocet products. The decision followed clinical evidence indicating that propoxyphene could cause potentially serious or fatal abnormalities in heart rhythm, even when taken at recommended doses.

Heart-rhythm disturbances can interfere with the heart’s ability to circulate blood effectively and may become life-threatening. Following the safety review, regulators determined that the risks of propoxyphene outweighed its benefits as a pain reliever. Approval for affected U.S. products was subsequently withdrawn.

For this reason, Darvocet-N 100 should be described as a discontinued medication in the United States, not as a currently marketed U.S. treatment.

Historical Side Effects and Safety Concerns

Historical prescribing information described possible effects such as nausea, vomiting, dizziness, drowsiness, and constipation. More serious concerns included opioid-related respiratory depression, overdose, dependence, and potentially dangerous cardiac effects.

Combining opioid medicines with alcohol, sedatives, or other substances that depress the central nervous system can increase the risk of severe sedation and breathing difficulties. Excessive acetaminophen intake can cause serious liver damage.

Anyone reviewing an old prescription should verify the product and ingredients rather than relying on the name or appearance of a tablet. If someone may have taken an unknown or discontinued medication and develops difficulty breathing, fainting, or an abnormal heartbeat, urgent medical evaluation is necessary.

Understanding the Former Formulation

The historical Darvocet-N 100 formulation contained propoxyphene napsylate 100mg and acetaminophen 650mg per tablet. It was distinct from Darvocet-N 50 and other medicines containing different propoxyphene salts or strengths. Similar product names do not necessarily indicate identical formulations.

When checking historical medication information, consult a reliable archived label or medical record. Do not use leftover or unidentified tablets based on an old prescription, online description, or visual resemblance.

Current Pain-Management Considerations

People seeking pain relief should speak with a qualified healthcare professional. The appropriate treatment depends on the cause and severity of pain, existing medical conditions, current medications, and individual risk factors. A clinician can explain available alternatives, expected benefits, potential side effects, and relevant precautions.

Conclusion

Darvocet-N 100 was a historical prescription pain medication containing propoxyphene napsylate 100mg and acetaminophen 650mg. It was withdrawn from the U.S. market because of serious cardiac safety concerns associated with propoxyphene. Its former ingredients and uses may be relevant to historical research, but it should not be represented as a currently marketed U.S. treatment. Consult a healthcare professional for current pain-management advice.